Projects per year
Fingerprint
Dive into the research topics where Rosa Lapalombella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Understanding Richter's Transformation in the targeted therapies era
Lapalombella, R. (PI)
09/11/20 → 05/31/25
Project: Research
-
OSU K12 Training Grant in Oncology
Carson, W. E. (CoPI), Byrd, J. C. (CoPI) & Lapalombella, R. (CoPI)
09/9/08 → 06/30/25
Project: Research
-
Targeting NAMPT in Acute Myeloid Leukemia
Lapalombella, R. (PI), Mims, A. (CoPI) & Sampath, D. (CoPI)
08/2/18 → 07/31/23
Project: Research
-
Targeted Therapies for Richters Transformation
Lapalombella, R. (PI), Baiocchi, R. A. (CoPI) & Byrd, J. C. (CoPI)
02/7/17 → 01/31/18
Project: Research
-
Dual targeting of XPO1 and BTK in B cell malignancies
Lapalombella, R. (PI), Blum, K. A. (CoPI), Byrd, J. C. (CoPI) & Woyach, J. A. (CoPI)
04/21/15 → 03/31/21
Project: Research
-
CD37 in acute myeloid leukemia: a novel surface target for drug delivery
Jeremy, E., Artiga, E., Elgamal, S., Cheney, C., Eicher, D., Zalponik, K., Orwick, S., Mao, C., Wasmuth, R., Harrington, B., Mustonen, A., Beshay, P., Halley, P., Castro, C., Williams, K., Hing, Z., Chen, T., Lucas, C., Vantangoli, N. J. & Lapalombella, R. & 7 others, , Jan 14 2025, In: Blood Advances. 9, 1, p. 1-14 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia
Ravikrishnan, J., Diaz-Rohena, D. Y., Muhowski, E., Mo, X., Lai, T. H., Misra, S., Williams, C. D., Sanchez, J. R., Mitchell, A., Satpati, S., Perry, E., Kaufman, T., Liu, C., Lozanski, A., Lozanski, G., Rogers, K. A., Kittai, A. S., Bhat, S. A., Collins, M. C. & Davids, M. S. & 11 others, , Jan 2025, In: Haematologica. 110, 1, p. 78-91 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL
Han, Q., Gu, Y., Xiang, H., Zhang, L., Wang, Y., Yang, C., Li, J., Steiner, C., Lapalombella, R., Woyach, J. A., Yang, Y., Dovat, S., Song, C. & Ge, Z., 2025, (Accepted/In press) In: Blood.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis
Saygin, C., Zhang, P., Stauber, J., Aldoss, I., Sperling, A. S., Weeks, L. D., Luskin, M. R., Knepper, T. C., Wanjari, P., Wang, P., Lager, A. M., Fitzpatrick, C., Segal, J. P., Gharghabi, M., Gurbuxani, S., Venkataraman, G., Cheng, J. X., Eisfelder, B. J., Bohorquez, O. & Patel, A. A. & 15 others, , May 1 2024, In: Blood cancer discovery. 5, 3, p. 164-179 16 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling
Marr, A. R., Halpin, M., Corbin, D. L., Asemelash, Y., Sher, S., Gordon, B. K., Whipp, E. C., Mitchell, S., Harrington, B. K., Orwick, S., Benrashid, S., Goettl, V. M., Yildiz, V., Mitchell, A. D., Cahn, O., Mims, A. S., Larkin, K. T. M., Long, M., Blachly, J. & Woyach, J. A. & 2 others, , Dec 2024, In: Experimental Hematology and Oncology. 13, 1, 27.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations